Jounce will lead development of JTX-1811 through IND clearance, after which Gilead will have the sole right to develop the drug. The company is perhaps better known for its lead candidate ...
Hosted on MSN27d
Philly Nonprofit Jounce Partners Helps Teachers Unlock Their Students’ Full PotentialJounce Partners, a Philadelphia nonprofit backed by M. Night Shyamalan, helps teachers bring out the best in their students by introducing them to the latest research-based teaching methods and ...
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, leads the market with 99% of CTV supply coverage and 96% of overall ...
WASHINGTON, March 3, 2025 /PRNewswire/ -- The Brand Safety Institute (BSI) is proud to announce the launch of an industry-first MFA Transparency Utility for Publishers in partnership with Ad Fontes ...
To better support media owners and buyers, Magnite offers: “The results of the Jounce study represent the culmination of the years we’ve spent building deep, strategic relationships with media ...
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, leads the market with 99% of CTV supply coverage and 96% of overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback